Grubbs, Jordan E.
Daigle, Haley J.
Shepherd, Megan
Heidel, Robert E.
Kleppe, Kyle L.
Mancini, Matthew L.
Mancini, Gregory J.
Article History
Received: 24 March 2022
Accepted: 11 September 2022
First Online: 26 September 2022
Declarations
:
: Dr Matthew Mancini has relationships with Olympus and CareSyntax as a consultant, additionally he receives support for academic travel from University of Tennessee Medical Center Knoxville General Surgery Department. He is also the secretary of the UT Day Surgery Advisory board for which he receives additional compensation, this does not present a conflict of interest as all bariatric surgeries are performed in the Main OR. He owns stock in Apple, which is making strides into the healthcare field but is not relevant to this paper. Dr Gregory Mancini receives fees as a consultant for CareSyntax. Dr Kleppe has also received consulting fees from CareSyntax. Drs Grubbs, Daigle, Shepherd, and Heidel have no disclosures.
Free to read: This content has been made available to all.